Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Digital technologies are being developed to address a broad range of health challenges.  Mental health challenges may seem particularly suited for a digital solution.  As mental disorders are experienced as behavioral or cognitive problems, digital phenotyping based on smartphone sensor data, keyboard performance, and voice/speech is especially promising for detecting and diagnosing anxiety, mood, or psychotic disorders.  In contrast to traditional assessments which are subjective, episodic, and clinic-based; digital phenotyping can deliver objective, continuous, and ecological assessments of behavior.  Because the assessment is passive and the technology is ubiquitous, there is understandable enthusiasm about this new approach to measuring behavior and cognition.  But will better measurement result in better outcomes?  We do not yet have the evidence to answer this question, although combining this afferent signal with the efferent use of online tools (from peer support to improved clinical management) may close the loop.  This lecture will explore the promise and problems of digital phenotyping and online treatments, arguing that better measurement will be fundamental to better management of mental disorders and describing the studies necessary to prove the clinical value and ensure the public trust for this new technology.